G42 Healthcare ramps up efforts to offer clinical genetic testing solutions in the UAE

G42 Healthcare, Abu Dhabi-based leading health-tech company, has scaled up efforts to offer its clinical genetic testing solutions in the UAE.

The company has launched over 250 comprehensive clinical genetic testing panels that use state-of-the-art sequencing technologies.

Dr Fahed Al Marzooqi, COO of G42 Healthcare, said: “As part of our efforts to support the health of future generations and provide better healthcare every day, Biogenix Labs is expanding its clinical genetics offering in the region and reinforcing its reputation as the regional testing provider of choice.”

The clinical genetic solutions, to be offered through Biogenix Labs – part of G42 Healthcare, are part of the company’s mission to provide insights and facilitate early diagnosis and treatment of cancer, rare and metabolic diseases and other genetic conditions in the region.

With a massive throughput laboratory built to address the need for population-scale detection and diagnosis of various infections, Biogenix is one of the first accredited labs in UAE. The laboratory is located in Masdar City.

The clinical genetics offering will soon be followed by the consumer genomics testing equivalent.